|
|
||||||||
1From the University Institute of Applied Ophthalmobiology (IOBA) and the 2Department of Human Anatomy, University of Valladolid, Valladolid, Spain; and 3Allergan Inc., Irvine, California.
PURPOSE. To characterize a new nontransfected, spontaneously immortalized epithelial cell line from normal human conjunctiva (IOBA-NHC), both morphologically and functionally, to determine whether the differentiated phenotype of conjunctival epithelial cells is preserved.
METHODS. Outgrowing cells from explanted conjunctival tissue were successively passaged and preliminarily characterized at passage 3 to assess epithelial origin. The cells were further characterized at passages 15 to 20, 40, 60, and 100 by analyzing (1) proliferation and in vitro behavior (viability, plating efficiency, colony forming efficiency and colony size, and Ki-67 protein expression), (2) karyotype and G-banding, (3) epithelial marker expression (cytokeratins, desmoplakins, EGF receptor), (4) absence of contaminating cell types, (5) expression of conjunctival differentiation markers (mucin gene expression), and (6) functional capability in response to proinflammatory stimuli. IOBA-NHC cells were analyzed by light and electron (transmission and scanning) microscopy, immunohistochemistry, electrophoresis and Western blot analysis, flow cytometry, and reverse transcription-polymerase chain reaction (RT-PCR).
RESULTS. IOBA-NHC cells showed high proliferative ability in vitro and typical epithelial morphology. Cytokeratins and GalNAc, GluNAc, mannose, and sialic acid residues were immunodetected in these cells. No contaminating cell types were found. MUC1, -2, and -4, but not -5AC or -7 mucin genes were expressed in every cell passage tested. Exposure of cells to inflammatory mediators (IFN
and/or TNF
) resulted in increased expression of intercellular adhesion molecule (ICAM)-1 and HLA-DR.
CONCLUSIONS. Morphologic and functional characterization of the nontransfected, spontaneously immortalized IOBA-NHC cell line shows that this new cell line may be a useful experimental tool in the field of ocular surface cell biology.
This article has been cited by other articles:
![]() |
A. Huhtala, S. Ronkko, M. Terasvirta, T. Puustjarvi, R. Sihvola, K. Vehanen, A. Laukkanen, J. Anttila, A. Urtti, T. Pohjonen, et al. The Effects of 5-Fluorouracil on Ocular Tissues In Vitro and In Vivo after Controlled Release from a Multifunctional Implant Invest. Ophthalmol. Vis. Sci., May 1, 2009; 50(5): 2216 - 2223. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Minsel, R. Mentlein, S. Sel, Y. Diebold, L. Brauer, E. Muhlbauer, and F. P. Paulsen Somatostatin Actions via Somatostatin Receptors on the Ocular Surface Are Modulated by Inflammatory Processes Endocrinology, May 1, 2009; 150(5): 2254 - 2263. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Li, H. Y. Zhu, and R. W. Beuerman Stimulation of Specific Cytokines in Human Conjunctival Epithelial Cells by Defensins HNP1, HBD2, and HBD3 Invest. Ophthalmol. Vis. Sci., February 1, 2009; 50(2): 644 - 653. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Iribarne, V. Torbidoni, K. Julian, J. P. Prestifilippo, D. Sinha, V. Rettori, A. Berra, and A. M. Suburo Cannabinoid Receptors in Conjunctival Epithelium: Identification and Functional Properties Invest. Ophthalmol. Vis. Sci., October 1, 2008; 49(10): 4535 - 4544. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. B. Cook, J. L. Stahl, F. M. Graziano, and N. P. Barney Regulation of the Receptor for TNF{alpha}, TNFR1, in Human Conjunctival Epithelial Cells Invest. Ophthalmol. Vis. Sci., September 1, 2008; 49(9): 3992 - 3998. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. de la Fuente, B. Seijo, and M. J. Alonso Novel Hyaluronic Acid-Chitosan Nanoparticles for Ocular Gene Therapy Invest. Ophthalmol. Vis. Sci., May 1, 2008; 49(5): 2016 - 2024. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Nilsson, F. Jamshidi, S. M. C. Johansson, M. S. Oberste, and N. Arnberg Sialic Acid Is a Cellular Receptor for Coxsackievirus A24 Variant, an Emerging Virus with Pandemic Potential J. Virol., March 15, 2008; 82(6): 3061 - 3068. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Brauer, C. Kindler, K. Jager, S. Sel, B. Nolle, U. Pleyer, M. Ochs, and F. P. Paulsen Detection of Surfactant Proteins A and D in Human Tear Fluid and the Human Lacrimal System Invest. Ophthalmol. Vis. Sci., September 1, 2007; 48(9): 3945 - 3953. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Narayanan, W. L. Miller, and A. M. McDermott Conjunctival cytokine expression in symptomatic moderate dry eye subjects. Invest. Ophthalmol. Vis. Sci., June 1, 2006; 47(6): 2445 - 2450. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. de Salamanca, Y. Diebold, M. Calonge, C. Garcia-Vazquez, S. Callejo, A. Vila, and M. J. Alonso Chitosan nanoparticles as a potential drug delivery system for the ocular surface: toxicity, uptake mechanism and in vivo tolerance. Invest. Ophthalmol. Vis. Sci., April 1, 2006; 47(4): 1416 - 1425. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Nokhbeh, S. Hazra, D. A. Alexander, A. Khan, M. McAllister, E. J. Suuronen, M. Griffith, and K. Dimock Enterovirus 70 Binds to Different Glycoconjugates Containing {alpha}2,3-Linked Sialic Acid on Different Cell Lines J. Virol., June 1, 2005; 79(11): 7087 - 7094. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. de Salamanca, K. F. Siemasko, Y. Diebold, M. Calonge, J. Gao, M. Juarez-Campo, and M. E. Stern Expression of Muscarinic and Adrenergic Receptors in Normal Human Conjunctival Epithelium Invest. Ophthalmol. Vis. Sci., February 1, 2005; 46(2): 504 - 513. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |